Aveanna Healthcare  Inc. logo

Aveanna Healthcare Inc.

AVAH | NASDAQ
Chart Builder DCF Calculator
$13.16
-$0.10 (-0.75%)
At close: Oct 30, 2026, 4:00 PM ET
$13.18
+$0.02 (+0.15%)
Pre-market: Nov 2, 2026, 9:00 AM ET

Market Data

Market Cap
$2.87B
Enterprise Value
$4.28B
Beta
1.95
Average Volume
2.8M
Shares Outstanding (Diluted)
224.86M
Shares Change YoY
6.85%
Institutional Ownership
92.96%
Exchange
NASDAQ
ISIN
US05356F1057

Price Performance

Price Change 1M
6.0%
Price Change 3M
40.1%
Price Change 6M
99.1%
Price Change YTD
61.1%
Price Change 1Y
45.4%
Price Change 3Y
853.6%
Price Change 5Y
70.5%
1M CAGR (ann.)
-3.7%
1Y CAGR (ann.)
33.5%
5Y CAGR (ann.)
12.8%
All-Time CAGR
1.7%

Valuation

PE Ratio
10.44
Forward PE
16.18
PEG Ratio
0.01
Forward PEG
0.24
PS Ratio
1.10
Forward PS
1.10
PB Ratio
10.00
P/FCF Ratio
17.32
P/Adj. FCF Ratio
16.15
P/OCF Ratio
17.09
EV/Sales
1.64
EV/EBIT
15.35
EV/EBITDA
14.31
EV/FCF
25.81
Earnings Yield
9.6%
FCF Yield
5.8%
Adj. FCF Yield
6.2%

Financial Health

Net Debt
$1.37B
Total Debt
$1.51B
Cash & Short-Term Investments
$97.2M
Total Assets
$2.11B
Current Ratio
1.16
Quick Ratio
1.16
Debt / Equity Ratio
5.24
Debt / EBITDA
5.03
Debt / FCF
9.08
OCF / Debt
0.11
Interest Coverage
2.32
Altman Z-Score
1.94
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
31.9%
Operating Profit Margin
11.1%
EBITDA Margin
11.8%
Net Profit Margin
10.6%
FCF Margin
6.4%
Adj. FCF Margin
6.8%
SBC / Revenue
-0.5%
SBC Impact (per share)
-7.2%

Returns

Return on Assets
13.0%
Return on Equity
150.2%
Return on Invested Capital
15.3%
Return on Capital Employed
17.1%
Return on Tangible Assets
37.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
12.4%
Revenue CAGR 5Y
9.7%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
426.5%
EPS CAGR 5Y
138.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
91.7%
FCF CAGR 5Y
60.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
8
EPS Growth Next 3Y
-9.1%
Revenue Growth Next 3Y
5.6%
Earnings Date
Nov 12, 2026
EPS Estimate (next Q)
$0.21
EPS Growth Est (next Q)
38.1%
Revenue Est (next Q)
$679.48M
Revenue Growth Est (next Q)
9.3%

Fair Value Estimates

Graham Number
$6.12
Graham Upside
-53.5%
Lynch Fair Value
$31.50
Lynch Upside
139.4%
Price Target
$14.38
Price Target Upside
9.3%

Cash Flow

Operating Cash Flow
$168.2M
Free Cash Flow
$165.83M
Adj. Free Cash Flow
$177.83M
FCF Per Share
$0.76
OCF Per Share
$0.77
OCF/S Ratio
6.5%

Income Statement

Revenue
$2.6B
Gross Profit
$831.71M
Operating Income
$289.47M
EBITDA
$299.15M
Net Income
$274.76M
EPS (Diluted)
$1.26
Revenue / Employee
$73.32K
Profit / Employee
$7.74K
Employees
35,500

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.